A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections
Clinical trial NCT05462756 · COMPLETED
Trial details
- NCT number
- NCT05462756
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-11
- Primary completion
- 2024-02-27
- Enrollment
- 730
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.